首页> 外文期刊>Acta Virologica: International Journal >Immunogenicity and antigenicity of a recombinant chimeric protein containing epitopes of poliovirus type 1
【24h】

Immunogenicity and antigenicity of a recombinant chimeric protein containing epitopes of poliovirus type 1

机译:包含1型脊髓灰质炎病毒表位的重组嵌合蛋白的免疫原性和抗原性。

获取原文
获取原文并翻译 | 示例
           

摘要

To design a vaccine that simultaneously prevents both rotavirus (RV) and poliovirus (PV), a PV type 1 (PV1) chimeric protein using RV VP6 as a vector (VP6F) was constructed, expressed in Escherichia coli expression system and characterized by SDS-PAGE, Western blot, immunofluorescence assay and neutralization test. The results showed that the chimeric protein reacted with anti-VP6F and anti-PV1 antibodies and elicited production of serum antibodies against the chimeric protein in guinea pigs. Antibodies against the chimeric protein neutralized RV Wa and PV1 infection in vitro. The results provided a relevant possibility of developing novel approaches in the rational design of vaccines effective against both RV and PV.
机译:为了设计同时预防轮状病毒(RV)和脊髓灰质炎病毒(PV)的疫苗,构建了以RV VP6为载体(VP6F)的PV 1型(PV1)嵌合蛋白,并在大肠杆菌表达系统中表达,并通过SDS- PAGE,蛋白质印迹,免疫荧光测定和中和测试。结果表明,该嵌合蛋白与抗VP6F和抗PV1抗体反应,并引发了豚鼠中针对该嵌合蛋白的血清抗体的产生。针对嵌合蛋白的抗体在体外中和了RV Wa和PV1感染。结果提供了在合理设计针对RV和PV的疫苗的合理设计中开发新方法的相关可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号